Found: 11
Select item for more details and to access through your institution.
Analysis of Cerebrospinal Fluid, Plasma β-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer's Disease Using Quantitative Systems Pharmacology Model.
- Published in:
- Drugs, 2024, v. 84, n. 7, p. 825, doi. 10.1007/s40265-024-02068-7
- By:
- Publication type:
- Article
Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer's Disease.
- Published in:
- Drugs, 2024, v. 84, n. 7, p. 811, doi. 10.1007/s40265-024-02067-8
- By:
- Publication type:
- Article
Nogapendekin alfa Inbakicept: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 7, p. 867, doi. 10.1007/s40265-024-02060-1
- By:
- Publication type:
- Article
Sotatercept: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 7, p. 857, doi. 10.1007/s40265-024-02058-9
- By:
- Publication type:
- Article
Zastaprazan: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 7, p. 863, doi. 10.1007/s40265-024-02057-w
- By:
- Publication type:
- Article
Correction: Iptacopan: First Approval.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Aprocitentan: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 7, p. 841, doi. 10.1007/s40265-024-02053-0
- By:
- Publication type:
- Article
Givinostat: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 7, p. 849, doi. 10.1007/s40265-024-02052-1
- By:
- Publication type:
- Article
Treatment Options in Spinal Muscular Atrophy: A Pragmatic Approach for Clinicians.
- Published in:
- Drugs, 2024, v. 84, n. 7, p. 747, doi. 10.1007/s40265-024-02051-2
- By:
- Publication type:
- Article
Drugs Targeting Cough Receptors: New Therapeutic Options in Refractory or Unexplained Chronic Cough.
- Published in:
- Drugs, 2024, v. 84, n. 7, p. 763, doi. 10.1007/s40265-024-02047-y
- By:
- Publication type:
- Article
Botulinum Toxin-A for the Treatment of Myogenous Temporomandibular Disorders: An Umbrella Review of Systematic Reviews.
- Published in:
- Drugs, 2024, v. 84, n. 7, p. 779, doi. 10.1007/s40265-024-02048-x
- By:
- Publication type:
- Article